Recently, chronic supplementation with zzso A zzso zzso has been approved as a treatment zzso for zzso zzso The aim of the current study was to investigate the feasibility of home therapy for zzso disease during a follow-up of zzso years and to make a proposal for practice zzso 

Based on experience in previous clinical trials, an zzso for home treatment eligibility was zzso The number of successful and zzso infusions was recorded, as well as adverse and zzso zzso The presence and zzso of zzso human zzso A zzso were monitored every 3 zzso 

Thirty of the 36 patients eligible for home treatment received a total of zzso infusions at home zzso 44 zzso range zzso between March 2001 and July zzso Mean age was zzso years zzso zzso patients receiving home treatment zzso were zzso The majority of patients (27 out of 30, zzso undergoing home treatment received zzso zzso zzso alpha or zzso Six male patients developed an zzso event, of which three developed these at zzso All patients with an zzso event were zzso A zzso positive at 3 months, but three patients with zzso A zzso did not develop side zzso zzso zzso between these patients did not zzso None of the events was life-threatening or necessitated urgent zzso 

Home treatment with zzso A for zzso disease with zzso zzso for males and both zzso and zzso zzso for females is feasible and safe, and reduces both the burden related to chronic intravenous therapy and health care zzso Whether this can also be applied for male patients treated with zzso zzso has not yet been zzso 
